COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 1525: Articles 15241-15250  | Next

From first to second wave: follow-up of the prospective Covid-19 cohort (KoCo19) in Munich (Germany)
Radon, K., Bakuli, A., Puetz, P., Le Gleut, R., Guggenbuehl Noller, J. M., Olbrich, L., Saathoff, E., Gari, M., Schaelte, Y., Frahnow, T., Woelfel, R., Pritsch, M., Rothe, C., Pletschette, M., Rubio-Acero, R., Beyerl, J., Metaxa, D., Forster, F., Thiel, V., Castelletti, N., Riess, F., Diefenbach, M. N., Froeschl, G., Bruger, J. M., Winter, S. M., Frese, J. L., Puchinger, K., Brand, I., Kroidl, I., Wieser, A., Hoelscher, M., Hasenauer, J., Fuchs, C., KoCo19 study group
10.1101/2021.04.27.21256133 — Posted: 2021-04-29
Sentinel seroprevalence of SARS-CoV-2 in the Gauteng province, South Africa August to October 2020.
George, J. A., Khoza, S., Mayne, E., Dlamini, S., Kone, N., Jassat, W., Chetty, K., Centner, C., Pillay, T., Maphayi, M. R., Mabuza, D. V., Maposa, I. A., Cassim, N.
10.1101/2021.04.27.21256099 — Posted: 2021-04-29
Local emergence and decline of a SARS-CoV-2 variant with mutations L452R and N501Y in the spike protein
Mallm, J.-P., Bundschuh, C., Kim, H., Weidner, N., Steiger, S., Lander, I., Börner, K., Bauer, K., Hübschmann, D., Benes, V., Rausch, T., Trevisan Doimo de Azevedo, N., Telzerow, A., Jost, K. L., Parthe, S., Schnitzler, P., Boutros, M., Müller, B., Bartenschlager, R., Kräusslich, H.-G., Rippe, K.
10.1101/2021.04.27.21254849 — Posted: 2021-04-29
Impairment of T cells' antiviral and anti-inflammation immunities dominates the death from COVID-19
She, Z.-s., Scholes, G., Zhang, L., Li, R., Song, G.
10.1101/2021.04.26.21256093 — Posted: 2021-04-29
Host-pathogen dynamics in longitudinal clinical specimens from patients with COVID-19
Lin, M. J., Rachleff, V. M., Xie, H. J., Shrestha, L., Lieberman, N. A., Peddu, V., Addetia, A., Casto, A., Breit, N., Mathias, P. C., Huang, M., Jerome, K., Greninger, A. L., Roychoudhury, P.
10.1101/2021.04.27.21256149 — Posted: 2021-04-29
Anti-SARS-CoV-2 antibody levels are concordant across multiple platforms but are not fully predictive of sterilizing immunity
Bradley, B. T., Bryan, A., Fink, S. L., Goecker, E. A., Roychoudhury, P., Huang, M.-L., Zhu, H., Chaudhary, A., Madarampalli, B., Lu, J. Y.-C., Strand, K., Whimbey, E., Bryson-Cahn, C., Schippers, A., Mani, N. S., Pepper, G., Jerome, K. R., Morishima, C., Coombs, R. W., Wener, M., Cohen, S., Greninger, A. L.
10.1101/2021.04.26.21256118 — Posted: 2021-04-29
Clinical manifestations of hospitalized COVID-19 patients in Bangladesh: a 14-day observational study
Shaha, M., Islam, M. A., Huq, F., Roy, B., Kabir, A., Salimullah, M., Mahtab, M. A., Akbar, S. M. F.
10.1101/2021.04.27.21256018 — Posted: 2021-04-29
Optimal allocation of vaccines - the role of childrens vaccination
Gavish, N., Katriel, G.
10.1101/2021.04.26.21256101 — Posted: 2021-04-29
Race-ethnicity and Perceptional Determinants of COVID-19 Vaccination Intentions: A Cross-sectional Study Among Health Workers and the General Population in the San Francisco Bay Area
Weng, Y., Lu, D., Bollyky, J., Jain, V., Desai, M., Lindan, C., Boothroyd, D., Judson, T., Doernberg, S. B., Holubar, M., Sample, H., Huang, B., Maldonado, Y., Rutherford, G. W., Grumbach, K., the California Pandemic Consortium
10.1101/2021.04.26.21255893 — Posted: 2021-04-29
Real world evidence of calcifediol use and mortality rate of COVID-19 hospitalized in a large cohort of 16,401 Andalusian patients
Loucera, C., Pena-Chilet, M., Esteban-Medina, M., Munoyerro-Muniz, D., Villegas, R., Lopez-Miranda, J., Rodriguez-Bano, J., Tunez, I., Bouillon, R., Dopazo, J., Quesada Gomez, J. M.
10.1101/2021.04.27.21255937 — Posted: 2021-04-29 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).